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Abstract
MTBE is found in water supplies used for drinking and other purposes. These experiments follow 
up on earlier reports of reproductive tract alterations in male mice exposed orally to MTBE and 
explored oxidative stress as a mode of action. CD-1 mice were gavaged with 400–2000 mg/kg 
MTBE on days 1, 3, and 5, injected ip with hCG (2.5 IU/g) on day 6, and necropsied on day 7. No 
effect was seen in testis histology or testosterone levels. Using a similar dosing protocol, others 
had initially reported disruption of seminiferous tubules in MTBE–gavaged mice, although later 
conclusions published were consistent with our findings. Another group had also reported 
testicular and other reproductive system abnormalities in male BALB/c mice exposed for 28 days 
to 80–8000 ug/ml MTBE in drinking water. We gave these MTBE concentrations to adult mice 
for 28 days and juvenile mice for 51 days through PND 77. Evidence of oxidative stress was 
examined in liver homogenates from the juvenile study using MDA, TEAC and 8OH2hG as 
endpoints. MTBE exposures at the levels examined indicated no significant changes in the male 
mouse reproductive tract and no signs of hepatic oxidative stress. This appears to be the first oral 
MTBE exposure of juvenile animals, and also the first to examine potential for MTBE to cause 
oxidative stress in vivo using a typical route of human exposure.
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1. Introduction
Methyl tert-butyl ether (MTBE) was adopted as a motor fuel oxygenate in the late 1970s to 
reduce tailpipe emissions of benzene and other air pollutants (1). Although use as a motor 
fuel additive has all but been eliminated in the U.S. since concerns arose about 
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environmental persistence and increasing presence in soils, groundwater and surface waters, 
MTBE is still detected in many water supplies in the U.S. and elsewhere that are used for 
drinking, cooking, bathing, and recreation (2). Uncertainties about the public health 
implications of chronic exposure to MTBE in water have focused mainly on reports from 
high dose, lifetime cancer bioassays in laboratory rodents. Cancers reported include 
increased Leydig cell tumors in rats exposed by inhalation or gavage, hepatic adenomas in 
female mice exposed by inhalation, and lymphohaematopoetic cancers in female rats treated 
by gavage (1), yet MTBE currently remains unclassifiable as to carcinogenic potential in 
humans. This is because of uncertainty about the reliability of the rodent tumor findings, 
relevance of these tumors seen in only some rodent species to human cancers, and 
applicability to typically low human exposure levels. For example, it is noteworthy that 
examination of male reproductive organs after lifetime exposure of rats and mice at identical 
high inhalation concentrations in the cancer bioassays had revealed Leydig cell adenomas in 
the testes of rats, but no effect in mouse testes or other reproductive organs. It is not yet 
known whether rats or mice, or either species, are indicative of human response in terms of 
health risks associated with MTBE exposure. Whether or not either turns out to be a 
preferred model for predicting human risk, it is important to be clear on whether effects 
reported only in brief abstracts can be substantiated.
In subchronic studies focusing specifically on reproductive endpoints no significant effects 
were reported initially in either male rats or male mice exposed by inhalation. Male CD 
(Sprague-Dawley) rats were exposed for 12 weeks to up to 3,400 ppm MTBE for 6 hr a day, 
5 days a week prior to mating with treated females (3). No adverse effect of treatment was 
observed in the male reproductive tract, and mating and fertility indices were no different in 
treated groups compared with air sham controls. No effects were seen in male reproductive 
organs following MTBE exposure of male rats exposed for 13 weeks or CD-1 mice exposed 
for 13 days to up to 8,000 ppm (1). A two generation study in CD Sprague-Dawley rats 
exposed to 8,000 ppm reported reductions of body weight gain early in treatment and in 
food consumption in the F0 and F1 males but no significant effects on reproductive 
parameters (4). Oral gavage studies conducted independently by two different laboratories 
had detected reduced circulating testosterone levels when blood was sampled within 1–2 hr 
after dosing male Sprague-Dawley rats (5,6). Doses used were high, up to 1,200–1,500 
mg/kg, to explore possible mechanisms underlying the rat Leydig cell tumors seen at high 
doses in cancer bioassays.
Preliminary reports of male mouse reproductive system abnormalities after MTBE orally for 
up to a month (7,8) were unexpected, however. This is because, unlike the rats, mice in 
cancer bioassays had no testicular abnormalities after lifetime exposures, and no other 
subchronic MTBE reproduction studies had reported histopathological changes in the mouse 
reproductive tract. The first objective of the experiments reported here was to follow up on 
these two abstracts. Billitti et al. (7) had gavaged CD-1 male mice with MTBE doses of 400, 
1000 and 2000 mg/kg on days 1, 3 and 5 of a 7-day study. Almeida et al. (8) had exposed 
male BALB/c mice through drinking water containing 80, 800 or 8000 ug/L (ppb) MTBE 
for 28 days. The abstract of the 7-day study had initially reported a small but significant 
increase in gross disruption of the seminiferous tubules at the 2000 mg/kg dose. After we 
had conducted a similar follow up experiment reported here and found no effect, the abstract 
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authors published their study with more details and a final conclusion of no MTBE 
treatment-related effects (9). The abstract of the 28-day drinking water study had reported an 
increase in abnormal seminiferous tubules, increased tubular diameters, decreased 
testosterone, increased testis and seminal vesicle weights, and decreased epididymal weights 
in animals exposed to MTBE (8). Full details of this study apparently have yet to be 
published.
A second objective in one of our experiments was to explore the possibility that oxidative 
stress may play a role in some of the toxic effects seen with MTBE. Previous studies 
addressing mechanisms underlying MTBE’s cancer-causing potential have described 
evidence of altered endocrine homeostasis (10); however, MTBE could have multiple modes 
of action. Increased hepatic lipid peroxidation had been reported in 6–9 week old male DDY 
mice given high intraperitoneal doses of MTBE (11). Glutathione and glutathione-S-
transferase, both contributors to the antioxidant protection system of cells, were unaffected 
in that study. Several groups had investigated the activity of MTBE in Ames Salmonella 
genotoxicity test strains sensitive to oxidative mutagens. One study reported a weak positive 
response in Ames Salmonella strain TA102 with an intact excision repair system but not in 
TA104 lacking excision repair capability (12). Others observed no MTBE effect in TA 104 
(13), and no effect of either MTBE or t-butyl alcohol, a metabolite of MTBE, in TA102 
(14). MTBE’s potential for causing oxidative stress has now also been studied in primary rat 
spermatogenic cells incubated with 0.5 uM to 5 mM MTBE (15). Reactive oxygen species, 
membrane lipid peroxidation, and extracellular superoxide dismutase increased, while 
cytosolic superoxide dismutase decreased. Like the experiments just mentioned, a second 
paper also appearing in the literature after we had completed our experiments describes 
other evidence of oxidative stress in male Sprague-Dawley rats (16). In those studies high 
gavage doses of MTBE ranging from 400 mg/kg to 1600 mg/kg were administered daily for 
14 or 28 days. These investigators postulated that other effects they observed in serum LH 
and FSH--which were sometimes increased and other times decreased relative to controls—
were explainable by adjustments in the positive and negative feedback loops present in the 
complex reproductive endocrine axis to maintain homeostasis. Serum malondialdehyde and 
total antioxidant ability in serum both increased, while testicular mRNA levels of 8-
oxoguanine glycosidase and extracellular superoxide dismutase also increased, all of which 
suggested increased oxidative stress in rats given high bolus doses. Oxidative stress was 
interpreted as a possible explanation for the reproductive system changes seen in rats given 
these high bolus MTBE doses.
MTBE is added to motor fuels to take advantage of its pro-oxidant properties; that is, it 
provides an additional oxygen source to promote more complete combustion of carbon fuels. 
The probability of oxygen radical formation increases as oxygen concentration increases, 
but this does not necessarily mean that oxygen radicals will be formed appreciably in 
mammalian tissues exposed to MTBE in excess of the body’s ability to detoxify them. To 
test this empirically, we incorporated several measures of oxidative stress into our final 
experiment.
The 7-day gavage experiment using adult CD-1 mice was patterned after Billitti et al. (7). 
Two additional drinking water studies consisted of a 28-day drinking water exposure in 
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adult mice and a 51-day exposure study in younger animals covering the period of weaning 
to the age of 77–78 days, both using the same mouse strain and MTBE concentrations used 
by Almeida et al (8). In addition, the livers from mice exposed for 51 days were analyzed for 
malondialdehyde as an indicator of lipid peroxidation, antioxidant capacity, 8-hydroxy-2’-
deoxyguanosine adducts. Our 51-day exposure study appears to be the first oral MTBE 
exposure of juvenile mice, and the first to explore oxidative stress in animals exposed to 
MTBE using a typical route of human exposure.
2. Materials and methods
2.1. Chemicals
MTBE (CAS# 1634-04-4) was purchased from Burdick & Jackson (7-day and 28-day 
exposure studies) or Sigma Aldrich (51-day exposure study). All other chemicals were from 
Sigma Aldrich or Fisher unless otherwise noted.
2.2. Animals
Adult male CD-1 mice in the one week gavage experiment were purchased from Charles 
River (Wilmington, MA). Adult male BALB/c mice used in the 28-day drinking water 
experiment were from Harlan (San Diego, CA). Just weaned juvenile BALB/c mice for the 
51-day drinking water exposure study were purchased from Taconic Farms, Inc. 
(Germantown, NY). All animals were housed in a humidity (55±10%) and temperature 
(70±4°C) controlled vivarium with a 12:12 light/dark cycle. Caging consisted of 
polycarbonate shoe boxes with wood chip bedding (Sani-Chips, SaddleBrook, NJ). Mice in 
the two drinking water experiments were housed singly to allow water consumption 
measurements for individual animals. Purina 5008 rodent chow was provided ad libitum 
along with tap water initially to all groups during acclimation. The San Diego State 
University Institutional Animal Care and Use Committee approved all procedures involving 
live animals.
2.3 Study designs
Approaches, endpoints, tissue preservation methods, analysis kits and other techniques were 
selected to parallel those used in the earlier 7-day and 28-day mouse studies (7,8) when 
those details could be determined and were also feasible to replicate. A few exceptions 
included increasing group sizes in our studies and adding epididymal sperm counts to the 
28-day experiment, assuming all deviations from the earlier study protocols could only add 
more useful information.
7-day gavage experiment—Following the exposure protocol described by Billitti et al., 
twenty-four adult male CD-1 mice (39–46 g, 96 days at the start of treatment) were 
randomly assigned to four groups: 0 (corn oil vehicle), 400, 1000 or 2000 mg/kg MTBE 
(n=6). Similarity of initial group body weight means and standard deviations was verified 
statistically before finalizing group assignments. Mice were gavaged with MTBE on days 1, 
3, and 5, and on day 6 each mouse was injected ip with 2.5 IU/g hCG to stimulate 
testosterone production. On day 7 mice were anesthetized with a ketamine/xylazine mixture 
(1 ml/kg of body weight) injected intramuscularly. Blood was obtained by cardiac puncture 
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before euthanasia by cervical dislocation. Organs were removed and weighed. Blood was 
placed immediately into Microtainer serum separator tubes, allowed to clot for 40 min, and 
then centrifuged at 10,000 g for 10 min at room temperature to produce serum for 
testosterone analysis. Testes were placed in Bouins fixative for 48 hr, then transferred to 
70% ethanol for shipment overnight to the histopathology lab.
28-day drinking water experiment—Drinking water concentrations were chosen to 
replicate the study by Almeida et al. (8). Twenty-four adult male BALB/c mice (n=6), 26–31 
g (127 days old when MTBE treatment began), were randomly assigned to the 0 (tap water), 
80, 800 and 8000 ppb (ug/L) MTBE experimental groups. Similarity of initial group body 
weight means and standard deviations was verified statistically before finalizing group 
assignments. After a 12-day acclimation period, the tap water provided to MTBE treatment 
groups was prepared to contain these concentrations of MTBE. Water consumption by each 
mouse was recorded daily. We had also conducted a two week palatability study prior to this 
using these concentrations of MTBE added to tap water and found no significant differences 
in water consumption. Food consumption and body weight gain were also not affected 
during this time by these levels of MTBE. Cage side observations were recorded daily. 
Euthanasia and serum and other tissue collection were performed as described above for the 
7-day study. Testes were placed in 2% glutaraldehyde fixative (Microscopy Science, 
Hatfield, PA) for histopathology analysis.
Almeida et al. (8) had reported using adult mice; however, we learned later that the age at 
which these animals had entered their study was 52 days (E. Hall, personal communication), 
so these mice could still have been just reaching sexual maturity during treatment, whereas 
our 28-day study mice had begun exposure at a later age. After determining this difference 
in study design, a third follow up experiment was scheduled to explore whether exposure of 
younger animals over an extended time period (51 days) might clarify or even intensify the 
effects reported by Almeida et al.
51-day drinking water exposure of juveniles—BALB/c mice used in this experiment 
were 22–23 days old (8–11 g) upon arrival. Animals were randomized into four groups 
(n=10): Tap water control, and those to receive MTBE concentrations of 80, 800, 8000 µg/L 
when exposure began. Similarity of initial group body weight means and standard deviations 
was verified statistically before finalizing group assignments. All appeared to be healthy and 
growing normally after a three day acclimation to the vivarium conditions, food and tap 
water provided. After a 3-day acclimation, MTBE was added to the drinking water to 
achieve the nominal concentrations noted above. General health status and amount of water 
consumed by each mouse was recorded daily. The MTBE exposure period continued for 51 
days until sacrifice at which time the mice were 76–77 days of age.
Mice were anesthetized with isoflurane before retro-orbital blood collection and final 
sacrifice by decapitation. Serum was prepared and aliquoted for hormone assays. Organs of 
interest were removed and weighed. One testis and associated epididymus were placed in 
Bouins fixative for 48 hr, then transferred to 70% ethanol before overnight shipment to the 
histopathology lab. Livers were removed, weighed, and snap frozen after mincing into 
smaller pieces to promote rapid freezing and facilitate evaluation of these tissues for 
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evidence of oxidative stress. The frozen liver tissues were sent to the Department of 
Toxicology at Indiana University for measurement of malondialdehyde as evidence of 
excessive lipid peroxidation (MDA assay), total antioxidant capacity (TEAC assay), and 8-
hyrdoxydeoxyguanine adducts.
2.4 Histopathology of testes and epididymides
Paraffin embedding, slide preparation and histopathology evaluations were completed by 
Colorado Histo-Prep (Ft. Collins, CO). H&E sections (5 micron) were evaluated for all dose 
groups in the 7-day gavage exposure experiment, and additional periodic acid/Schiff 
(PASH)-stained slides were evaluated for samples in the highest dose and control groups. 
H&E- and PASH-stained testicular sections (5 micron) were evaluated for all mice in the 
28-day exposure experiment. In both of these studies one testis was oriented for complete 
cross section observations and the other for complete longitudinal section. In the juvenile 
exposure study, complete cross sections were prepared of the testes and both cross sections 
and longitudinal sections of the epididymides. H&E and PASH sections (5 microns) were 
evaluated for each mouse. Seminiferous tubule diameters were measured in our laboratory 
using the H&E-stained slides and an Olympus light microscope with calibrated graticule.
Histopathological lesions considered to be significant were as follows: For testes, tumors, 
abnormal vasculature, abnormal interstitium, signs of inflammation and presence of large 
mononuclear or multinucleated cells, mineralization, and within the seminiferous tubules 
evidence of degeneration, abnormal germinal cell progression, or abnormal Sertoli cells. For 
epididymides, tumors, abnormal vasculature, signs of inflammation, or abnormal sperm 
organization.
2.5 Serum hormones
Testosterone Correlate-EIA™ kits (Assay Designs, Inc., Ann Arbor, MI) were used in the 7-
day and 28-day exposure studies. Serum was extracted following kit instructions, except that 
the extraction solvent was 2.0 ml ethyl acetate:hexane (3:2) instead of diethyl ether. Sample 
and extraction solvent were placed in glass extraction tubes, vortexed for 30 seconds, and 
then quick frozen in a dry ice/ethanol slurry. The top solvent layer was decanted into a clean 
glass tube, which was then placed in a water bath at 41.5°C and dried under compressed air 
flow for 20 min. Samples were then reconstituted in 250 ul of Assay Buffer 3 by vortexing 
well and allowing to sit and stabilize at room temperature before repeating the extraction. 
All extracted samples from a given experiment were analyzed in duplicate in a single assay 
following kit instructions. Typical intra-assay variability was 7.25% (CV) or less. 
Testosterone and 17β-estradiol were measured in duplicate samples of unextracted serum 
collected from mice in the juvenile exposure study using ELISA kits not requiring prior 
extraction and optimized for small sample volumes (Cayman Chemical Company, Ann 
Arbor, MI). Several repeat assays and sample dilutions were necessary to place all samples 
within the linear range of the standard curve.
All ELISAs were performed at least twice on aliquots of the same samples on different days 
to establish that trends observed in mice within a group and relative differences between 
group means were as shown in the representative assays shown in the tables. Values for 
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normal control male mouse serum testosterone were expected to be ~10–15 ng/ml based on 
literature values using radioimmunoassay techniques. To establish accuracy of these kits, 
commercially available reference control serum samples were analyzed alongside the 
experimental samples, and these fell within the expected reference control range.
Serum collected after an hCG challenge that was done in the 7-day study to compare with 
Billitti et al. (7,9) demonstrates potential of the treated mouse testes to respond to an LH-like 
gonadotropin and to produce and release testosterone. No hCG challenge was done in either 
the 28-day or 51-day experiments and a similar assay kit was used in order to allow more 
direct comparison of our serum testosterone results with those reported by Almeida et al. In 
those experiments, studying non-hCG challenged animals provided a different insight as to 
whether the entire reproductive endocrine axis still functioned similarly to tap water vehicle 
controls.
2.6 Sperm counts
The 28-day exposure study endpoints included epididymal sperm counts. After weighing 
epididymides, the caudae were removed, weighed together and then placed in a Petri dish 
containing 2.0 ml of phosphate buffered saline (PBS). The two caudae were then minced to 
release sperm. The resulting suspension was filtered into a clean test tube through 80 micron 
mesh silkscreen cloth to remove fibrous tissue and other debris from the sperm suspension. 
An additional 2.0 ml of PBS was then added to dilute the sperm suspension. Each sample 
was mixed gently before counting sperm cells on a Neubauer hemacytometer. The dose 
group assignment for each sample was concealed from the scorer until after sperm counts 
were completed.
2.7 Oxidative stress endpoints
We chose to study lipid peroxidation and other oxidative stress endpoints in liver for several 
reasons. First, it is widely recognized that MTBE undergoes metabolism in the liver, and this 
is often the tissue of choice when it is not known whether a metabolite or the parent 
compound might have this effect. The liver had been used in the only study of lipid 
peroxidation potential of MTBE in publication at the time our experiments were conducted 
(11), and we considered analyzing other tissues as well, yet a primary objective was initially 
to follow up on that study. In addition, substantial tissue mass such as the liver provides was 
needed for a thorough job with the specific and complementary oxidative stress assays we 
wanted to use.
Pieces of liver from the juvenile study animals ranging from 0.5 to 1.0 g were thawed and 
homogenized. Aliquots from each mouse liver sample were designated for total protein, 
malondialdehyde, Trolox equivalent antioxidant capacity, and 8-hydroxy-2-deoxyguanine 
adducts. Samples not used immediately remained stored at −80°C. Total protein was 
determined using a Pierce BCA protein assay kit (Pierce, Rockford IL).
Malondialdehyde (MDA)—The MDA protocol was based on published methods (17,18). 
A derivative of MDA is formed with 2,4-dinitrophenylhydrazine (DNPH) at low pH. High 
performance liquid chromatography (HPLC) isolates this specific derivatized MDA analyte 
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of interest from the complex liver homogenate mixture, and uses UV detection to quantify 
this derivative. The 1 mM TEP (1,1,3,3-tetraethoxypropane) stock solution used to make an 
MDA analytical standard was made by acidifying TEP and then diluting immediately before 
the assay to be completed that day. The rest of the assay was performed as described by Pilz 
et al. (17) with only minor alterations. A 250 µl aliquot of homogenized sample was mixed 
with DNPH to form the DNPH derivative of MDA. While protecting the samples from 
overexposure to UV light after addition of DNPH, each sample was then extracted with 1.0 
ml of hexane, then dried down under nitrogen gas. The dried sample was then redissolved in 
200 µl of 40:60 acetonitrile:water. The sample was vortexed briefly before loading into the 
HPLC. HPLC analysis was performed on a Waters Alliance 600S System equipped with a 
Waters 996 photodiode array detector, a Waters 717 auto injector sampler and Millennium32 
version 4.0 software. Chromatograms were acquired at 290 nm. A Waters symmetry C18 
column (3.9 × 50 mm) was used. Elution of the sample was conducted on a linear gradient 
with a mobile phase A of acetonitrile in water (10:90, v/v) and a mobile phase B of 
acetonitrile.
Trolox Equivalent Antioxidant Capacity (TEAC)—Changes in the antioxidant 
defense system of an organism indicate prior exposure to agents causing oxidative damage. 
The TEAC assay measures the presence of antioxidants in a sample during the generation of 
the radical cation 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt 
(ABTS). The protocol used was a modification of published methods (19). All reagents were 
purchased from Sigma Aldrich with the exception of ABTS, which was purchased from 
Fluka. Trolox used as an antioxidant standard in this assay was prepared in phosphate 
buffered saline, pH 7.4, at a 1/20× dilution. A Tecan Infinite M200 plate reader (Tecan, 
Durham, NC) with absorbance set at 660 nm was used to quantify antioxidant in the 
samples, all of which were analyzed in duplicate. A Magellan version 1.0 software system 
controlled all analytical equipment and carried out the data processing.
8-Hydroxy 2-deoxyguanosine (8OH2dG)—A measure of DNA oxidative damage is 
the oxidative modification of DNA bases, in particular the C-8 hydroxyl adduct of guanine 
(20). Of the total oxidized products that are known to occur in DNA, 8-oxo-2’-
deoxyguanosine and oxo8Gua represent approximately 5% (21). The frequency of these 
oxidized products and their ability to be measured by electrochemical detection make the 
8OH2dG assay a reliable and sensitive measure of oxidative stress-induced changes in the 
DNA structure. DNA isolation, hydrolysis and analysis of liver homogenates were 
conducted according to previously published protocols (21,22). All reagents were analytical 
grade and were purchased from Sigma Aldrich, Fisher or Fluka. HPLC analysis was 
performed on a Waters 2695 System equipped with a Waters 996 photodiode array detector. 
The column used with the system was a Supelco LC-18-DB (15 cm × 4.6 cm, 3 µm) with a 
guard column. 8OH2dG was detected by the ESA CoulArray electrochemical detector set at 
100 mV and 400 mV, and 2’-deoxyguanosine (2dG) was detected by the Waters photodiode 
array detector set at 290 nm. The amounts of 8OH2dG and 2dG in samples were quantitated 
from their respective calibration curves, and the ratio of 8OH2dG/2dG was compared among 
different experimental groups to assess the amount of oxidative DNA damage related to 
treatment.
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2.8 Statistical analysis
Body and organ weight, testosterone, sperm count, and oxidative stress measurement data 
were analyzed using ANOVA. Dunnett’s t-test would be applied if between-group 
differences were significant (p<0.05). Statistical software used was SPSS for Windows 
version 11 (SPSS Inc, Chicago, IL) for the adult mouse study data and GraphPad Prism 5 for 
Windows, Version 5.00, March 7, 2007 (GraphPad Software, Inc. San Diego, CA) for the 
juvenile mouse data.
3. Results
3.1 7-day gavage experiment
Some animals in the 2,000 mg/kg dose group were ataxic and lethargic for up to 60 min 
each time they were gavaged with MTBE. No significant body or organ weight differences 
were found at necropsy (Table 1). No noticeable MTBE-treatment related differences were 
observed in either histological findings in the testes (Table 2) or in group mean serum 
testosterone which was, as expected, higher in all groups following the challenge dose of 
hCG than levels found in normal mouse serum. The only testicular abnormality noted in the 
pathology report was in one control animal with mild unilateral seminiferous tubule 
degeneration. A mouse in the 8000 ppb MTBE group had an abscess of the preputial gland, 
a common occurrence in male mice.
Testosterone values showed considerable variability within groups. It was interesting to note 
in this experiment that a control mouse with unilateral degeneration of the seminiferous 
tubules, the only testicular abnormality in the pathology report, also had the highest 
testosterone value measured (68.35 ng/ml). On the other hand, the second lowest 
testosterone value in this experiment (8.65 ng/ml) was observed in another control mouse 
with no abnormal testicular histology.
3.2 28-day drinking water experiment in adult mice
Drinking water consumption was similar in all groups for this experiment (Table 3) and 
mean MTBE consumed was calculated from this. No significant treatment-related 
differences were seen in group mean body weight or organ weights (Table 4). No clear 
MTBE dose-related effect was seen in group mean serum testosterone, sperm per mg cauda, 
or testis histology (Table 5). Minimal or mild degeneration of seminiferous tubules observed 
in some control mice in addition to treated mice indicated that this was not related to MTBE 
exposure. All testicular lesions noted were graded as minimal (grade 1) except for one tap 
water control mouse with unilateral mild degeneration (grade 2).
3.3 51-day drinking water experiment in juvenile mice
All mice remained active and vigorous throughout the exposure period. These MTBE 
concentrations added to drinking water did not significantly affect average daily water 
consumption by mice beginning exposure soon after weaning (25–26 days) up to 76–77 days 
of age (Table 3). Absolute group mean body weights and reproductive and other organ 
weights were similar across the groups after 51 days of exposure (Table 6). When expressed 
as relative organ:body weight ratio, the 80 ppb group relative seminal vesicle mean weight 
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and the 800 ppb group relative lung mean weight were both increased over tap water control 
weights (p<0.05). This finding did not appear to be related to MTBE exposure insofar as 
there was no indication of a dose response in the seminal vesicle weights. One mouse in the 
800 ppb group had a lung mass that was approximately twice the size of the others in that 
group, and without that mouse that group relative mean increase would not have been 
statistically significant. Even still, the tendency toward increasing lung weights as drinking 
water concentration increased seemed more likely attributable to MTBE exposure. Bloody 
lung was noted during necropsy for several MTBE treated animals, including the mouse 
with unusually heavy lungs, and also for one tap water control. Possible underlying causes 
were not explored further at that time, our main focus being on other organs. No differences 
were observed in mean seminiferous tubule diameters or abnormal histology in testes or 
epididymides (Table 7).
Serum testosterone was more variable than expected, possibly because the manufacturer’s 
protocol did not require an extraction step. Whereas eliminating assay steps can sometimes 
reduce variability, using an assay kit that did not require an additional ether extraction step 
in the 51-day experiment did not seem reduce within group variability in that experiment, 
which tended to be even higher than in the 28-day experiment. Inherent biological 
variability and possibly also interindividual differences in MTBE consumption could also 
have contributed to variability.
This assay was repeated several times for all samples to confirm that the trends observed in 
individual mice within a group and between groups was as reflected in the final repeat assay 
shown in Table 8. Only the lowest 80 ppb group mean was lower than the control mean (not 
statistically significant). The distribution of lower values than the published normal range 
(10–15 ng/ml) was approximately the same in all groups: Seven of 10 mice in the control, 
800 and 8000 ppb dose groups, and nine of 10 in the 80 ppb group were much lower than in 
normal sexually mature male mice. Serum estradiol levels were less variable. Neither 
hormone varied statistically across the groups or suggested a clear dose-response.
Oxidative stress endpoints measured in livers show no evidence of differences resulting 
from the exposure conditions in the 51-day juvenile mouse experiment (Table 9). The 
8OH2dG adducts were measured in one-half of the animals in each treatment group; that is, 
20 liver samples of the original 40 samples collected. This assay was completed after the 
MDA and TEAC assays, and negative results from the TEAC and malondialdehyde assays 
led to the expectation of minimal if any 8OH2dG level increase. The decision was made 
then to analyze only the first half of the samples in the more costly 8OH2dG assay. The 
second half was not analyzed when no group differences were seen.
Taken together, our studies consistently showed no significant differences in male mouse 
organ weights, testis and epididymal histology, serum testosterone, and caudal sperm counts 
between the control group and the treated groups with acute gavage exposures up to 2000 
mg/kg and subchronic drinking water exposures up to 8000 ppb MTBE in drinking water.
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4. Discussion
These three oral dosing studies could not confirm findings of adverse MTBE treatment-
related effects on the male mouse reproductive tract noted previously in abstracts by other 
researchers. By the time our 7-day multiple dosing experiment was completed, Billitti et al. 
had reevaluated their data and concluded that testis histology and serum testosterone levels 
were in fact no different from control levels (9), confirming what we had also found using a 
similar study design.
Our 28-day adult and 51-day juvenile drinking water experiments could not confirm any of 
the male reproductive tract effects briefly summarized in the abstract by Almeida et al (2). 
These researchers had observed reduced serum testosterone in the 800 ug/L (ppb) and 8000 
ug/L dose groups and reduced epididymal weights at 800 ug/L, but no abnormal 
morphology in the caput epididymus. Epididymal observations were not reported for the 
8000 ppm group. In a separate experiment using the same exposure regimen these 
researchers had also observed significantly increased combined testes weights in all dose 
groups (80, 800 and 8000 ug/L) and measurable dose-related increases in both seminiferous 
tubule diameters and percent abnormal tubules. The reason for different findings in our 
studies and theirs are not readily apparent. MTBE ingestion in the highest dose groups in our 
28-day and 51-day exposure studies was approximately 30 or 40 ug/day/mouse, respectively
—slightly higher than the maximum of 22.96 ug/day/mouse reported by Almeida et al. over 
their 28-day study. The 51-day exposure period of our juvenile mice from PND 25–26 to 
76–77 days of age exceeded the 28-day exposure period used by the other group and, as far 
as we can determine, included the same period of maturation from PND day 52 to PND 80.
In general, testosterone values were more variable than we had expected to see based on 
extensive prior experience with radioimmunoassays of rat serum. Since high variability can 
mask differences between groups, experimental and biological variables were considered 
that could contribute to overall variability in serum testosterone. The ELISA kits used gave 
us lower testosterone values than we expected, but assay quality control measures employed 
indicated that the kits were performing satisfactorily. Biological variability may have had a 
lot to do with variability seen within groups Regularly measuring drinking water 
consumption by individually caged mice (Table 3) allowed analysis of interindividual 
differences (coefficient of variation) in mean water consumption per mouse within each 
group. This was between 6% and 11% in all treatment groups except for the tap water 
controls in the 28-day experiment, which varied 15%. In the 51-day experiment we 
suspected that the young age of these mice could also potentially add to the overall 
variability; that is, mice were just reaching sexual maturity at 51 days, which could result in 
some individuals either not having acquired the ability to produce stable levels of 
testosterone, in addition to possibly being more sensitive to MTBE than others.
After no significant effects were seen in the first two experiments, we expanded our focus 
on the male reproductive tract in the third experiment by including an investigation of the 
potential for MTBE to cause oxidative stress, applying three complementary measures to all 
liver homogenates from these male mice. Increased mouse liver tissue levels of MDA were 
predicted based on findings of a previous report (11). These researchers had conducted acute 
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ip dosing studies using 6–9 week old male DDY mice: A 50 mg/kg, 200 mg/kg and 500 
mg/kg MTBE dose study, and two studies involving one-week and four-week daily dosing 
with 50 mg/kg and 200 mg/kg. Their single 500 mg/kg dose had reportedly increased lipid 
peroxidation in liver homogenates 24 hr after dosing but this was not seen 48 hr after this 
‘one shot’ treatment. In their multi-day dosing studies an increase in lipid peroxidation was 
observed only in the higher, 200 mg/kg MTBE dose group after four weeks of daily ip 
injections.
Our MDA assay findings indicated no evidence of increased mouse liver lipid peroxidation 
after 51 days of drinking water containing MTBE and averaging intakes as high as 39.17 ug 
MTBE/day/mouse. Dividing this average daily intake by the mean final body weight of mice 
in this experiment (26 g) results in an approximate daily ingestion dose of 1.5 mg/kg/day. 
Use of a more prolonged and more typical route of human exposure, although with high 
concentrations of MTBE (up to 8,000 ppm), resulted in daily doses consumed by our mice 
that were less than 1/10 of the ‘one shot’ doses used by Katoh et al. (11). High bolus ip 
doses given to their DDY mice would have resulted in greater peak blood MTBE levels than 
would be expected with gradual MTBE intake associated with our drinking water ingestion. 
The increased lipid peroxidation they reported at 24 hr was no longer evident 48 hr after 
dosing, possibly suggesting a transient effect that could have been mitigated by antioxidant 
defense and other detoxification and elimination mechanisms of the body. In addition to 
exposing a younger animal (juvenile vs. adult) and different strain of mouse, we also used a 
more specific MDA measurement method than was used by Katoh et al. (11). HPLC 
separation and detection of a fluorescent derivative of MDA provides a more specific and 
sensitive indication of oxidative breakdown of lipids resulting in accumulation of MDA than 
the thiobarbituric acid (TBA) colorimetric assay used by Katoh et al (11). The standard TBA 
assay measures not only MDA but also other TBA-reactive substances present in the 
sample. A route and dose rate more typical of normal human environmental exposures, and 
greater specificity in measuring MDA, could alone account for different experimental 
results. Consistent with the lack of MDA increase we also saw no changes in antioxidant 
capacity (TEAC) or DNA-altering effect of MTBE in terms of 8OH2dG adducts. Absence 
of an MTBE effect on 8OH2dG adducts is also consistent with the Ames Salmonella 
genotoxicity studies finding no evidence of DNA alteration using strains for detecting 
oxidative mutagens (13,14).
The isolated rat spermatogenic cell exposure experiments demonstrating increases in 
membrane lipid peroxidation and ROS (15) are more difficult to relate to our lack of 
oxidative stress response in vivo without knowing blood or testicular tissue levels of MTBE 
reached in our study. The other group had used a standard, colorimetric TBA reactive-
substance assay protocol without prior sample purification, such as more selective method 
we used involving HPLC, so were not necessarily measuring only the lipid peroxidation 
MDA byproduct. The continued use of isolated cell cultures to explore the ability of MTBE 
to affect levels of reactive oxygen species could provide useful information, although 
keeping in mind that intact organisms have multiple powerful defense systems that protect 
against xenobiotics causing toxicity through an oxidative stress mode of action. Metabolic 
activation and detoxification capacities are both especially high in the liver, although both 
liver and testis contain similar antioxidant defense systems to deal with excess free radicals 
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generated during P450-mediated steroidogenesis and other metabolic reactions that occur in 
both organs.
A subsequent in vivo reproductive toxicity publication by Li et al. (16) appeared after all of 
our experiments were completed showed serum testosterone to be lower in male rats 
gavaged with high doses of MTBE for 14 or 28 days. Seeing this effect in rats was not 
surprising to us, since we and others had reported similar testosterone-lowering effects in 
Sprague-Dawley rats given high bolus doses (5,6). Other effects on rat testes might be 
expected given the high MTBE doses those rats received. Altered sperm morphology and a 
trend toward increased epididymal sperm counts with increasing doses after 28 days of 
MTBE treatment along with disordered seminiferous tubule contents after either 14 or 28 
days, had not been reported before, however. In fact, Robinson et al. [23] had observed no 
treatment-related histopathological findings in testes after 14 or 90 days of gavaging 
Sprague-Dawley rats with up to 1200 mg/kg MTBE. It should also be noted that Robinson’s 
reported less mortality by the end of their studies than was evident in the data tables 
presented by Li et al. showing reduced animal numbers in all experimental groups at 28 
days.
In addition to focusing on mice rather than rats, and observing no early mortality in any of 
the experimental groups, our juvenile mouse experiment used a drinking water exposure that 
was more similar to how humans could be exposed to MTBE. A different protocol would be 
used if the goal is to determine in mice whether any oral dose of MTBE could cause changes 
indicative of either oxidative stress or a reproductive hormone imbalance. There are no data 
from studies in rats using a comparable dosing regimen with which to compare our drinking 
water exposure testosterone data: Only studies reporting testosterone reduction after high 
bolus gavage doses. No MTBE+hCG challenge studies that we know of have been 
conducted using rats. All MTBE studies that we could locate that measured testosterone 
reported using radioimmunoassays.
Drinking water concentrations used in our studies far exceed current water quality 
guidelines for MTBE. The range of 80–8,000 ppb MTBE concentrations was approximately 
2–200 times greater than the EPA’s suggested consumer acceptability level of ≤ 20–40 µg/L 
(4). Our studies to-date reveal no evidence that MTBE alters the male mouse reproductive 
tract at drinking water concentrations that are much higher than most people would tolerate 
in terms of taste and odor.
Acknowledgment
A graduate student grant-in-aid to the SDSU Research Foundation from Lyondell Chemical Company helped 
support portions of this study.
References
1. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for MTBE. 
U.S. Department of Health and Human Services, Public Health Service; 1996. 
2. Davis MJ, Farland WH. The paradoxes of MTBE. Tox Sci. 2001; 61:211–217.
3. Biles RW, Schroeder RE, Holdsworth CE. Methyl tertiary butyl ether inhalation in rats: A single 
generation reproduction study. Toxicol Indust Health. 1987; 3:519–534.
de Peyster et al. Page 13
Reprod Toxicol. Author manuscript; available in PMC 2015 September 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
4. Bevan C, Neeper-Bradley TL, Tyl RW, Fisher LC, Panson RD, Kneiss JJ, Andrews LS. Two-
generation reproductive toxicity study of methyl tert-butyl ether (MTBE) in rats. J Appl Toxicol. 
1997; 17(S1):S13–S19. [PubMed: 9179723] 
5. Williams TM, Cattley RC, Borghoff SJ. Alterations in endocrine responses in male Sprague-Dawley 
rats following oral administration of methyl tert-butyl ether. Tox Sci. 2000; 54:168–176.
6. de Peyster A, MacLean KJ, Stephens BA, Ahern LD, Westover CM, Rozenshteyn D. Subchronic 
studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer. 
Tox Sci. 2003; 72:31–42.
7. Billitti JE, Faulkner BC, Wilson BW. Acute testicular toxicity of MTBE and breakdown products in 
lab mice. Toxicologist. 1999; 48 (abstract #1255). 
8. Almeida L, Pascale C, Hall E. The effects of methyl tertiary-butyl ether on mouse testis. 
Toxicologist. 2004; 78(S-1):188. (abstract #914). 
9. Billitti JE, Faulkner BC, Wilson BW. Absence of acute testicular toxicity of methyl-tert butyl ether 
and breakdown products in mice. Bull Environ Contam Toxicol. 2005; 75(2):228–235. [PubMed: 
16222491] 
10. Cruzan G, Borghoff SJ, de Peyster A, Hard GC, McClain M, McGregor DB, Thomas MG. Methyl 
tertiary-butyl ether mode of action for cancer endpoints in rodents. Reg Toxicol Pharmacol. 2007; 
47:156–165.
11. Katoh T, Arashidani K, Kikuchi M, Yoshikawa M, Kodama Y. Effects of methyl tertiary-butyl 
ether on hepatic lipid peroxidation in mice. Nippon Eiseigaku Zasshi. 1993; 48:873–878. 
[PubMed: 8254995] 
12. Williams-Hill D, Spears CP, Prakash S, Olah GA, Shamma T, Moin T, Kim LY, Hill CK. 
Mutagenicity studies of methyl-tert-butyl ether using the Ames tester strain TA102. Mutat Res. 
1999; 446:15–21. [PubMed: 10613182] 
13. Kado N, Kuzmicky P, Loarca-Pina G, Mumtaz M. Genotoxicity testing of methyl-tertiary butyl 
ether (MTBE) in the Salmonella microsuspension assay and mouse bone marrow micronucleus 
test. Mutat Res. 1998; 412:131–138. [PubMed: 9580226] 
14. McGregor DB, Cruzan G, Callander RD, May K, Banton M. The mutagenicity testing of tertiary-
butyl alcohol, tertiary-butyl acetate™ and methyl tertiary-butyl ether in Salmonella typhimurium. 
Mutat Res. 2000; 565:181–189. [PubMed: 15661616] 
15. Li D, Yin D, Han X. Methyl tert-butyl ether (MTBE)-induced cytotoxicity and oxidative stress in 
isolated rat spermatogenic cells. J Appl Toxicol. 2007; 27:10–17. [PubMed: 17177168] 
16. Li D, Chuntao Y, Gong Y, Huang Y, Han X. The effects of methyl tert-butyl ether (MTBE) on the 
male rat reproductive system. Food Chem Toxicol. 2008; 46:2402–08. [PubMed: 18467015] 
17. Pilz J, Meineke I, Gleiter CH. Measurement of free and bound malondialdehyde in plasma by high-
performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatog B 
(Analytical Technologies in the Biomedical and Life Sciences). 2000; 742(2):315–325.
18. Mateos R, Goya L, Bravo D. Determination of malondialdehyde by liquid chromatography as the 
2,4-dinitrophenylhydrazone derivative - A marker for oxidative stress in cell cultures of human 
hepatoma HepG2 cells. J Chromatog, B (Analytical Technologies in the Biomedical and Life 
Sciences). 2004; 805(1):33–39.
19. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity 
applying an improved ABTS radical cation decolorization assay. Free Rad Biol Med. 1999; 
26:231–1237.
20. Loft S, Poulsen HE. Markers of oxidative damage to DNA: Antioxidants and molecular damage. 
Methods Enzymol. 1999; 300:166–184. [PubMed: 9919520] 
21. Helbock HJ, Beckman K, Ames B. 8-hydroxydeoxyguanosine and 8-hydroxyguanine as 
biomarkers of oxidative DNA damage. Methods Enzymol. 1999; 300:156–166. [PubMed: 
9919519] 
22. Wang L, Hirayasu K, Ishizawa M, Kobayashi Y. Purification of genomic DNA from human whole 
blood by isopropanol-fractionation with concentrated NaI and SDS. Nucleic Acids Res. 1994; 
22:1774–1775. [PubMed: 8202389] 
23. Robinson M, Bruner RH, Olson GR. Fourteen- and ninety-day oral toxicity studies of methyl 
tertiary-butyl ether in Sprague-Dawley rats. J Am Coll Toxicol. 1990; 9:525–540.
de Peyster et al. Page 14
Reprod Toxicol. Author manuscript; available in PMC 2015 September 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
de Peyster et al. Page 15
Table 1
Body and organ weights after MTBE gavage exposure: 7-day study in adult male CD-1 mice
Corn oil control 400 mg/kg
MTBE
1000 mg/kg
MTBE
2000 mg/kg
MTBE
Absolute weight (g)
Final body weight 42.3 ± 1.90 41.8 ± 2.21 42.3 ± 2.02 42.2 ± 2.09
Testes 0.255 ± 0.033 0.242 ± 0.023 0.278 ± 0.022 0.248 ± 0.031
Epididymides 0.108 ± 0.008 0.110 ± 0.008 0.111 ± 0.009 0.116 ± 0.006
Seminal vesicles 0.302 ± 0.067 0.321 ± 0.081 0.308 ± 0.037 0.326 ± 0.045
Liver 2.24 ± 0.236 2.26 ± 0.215 2.15 ± 0.281 2.12 ± 0.213
Brain 0.490 ± 0.023 0.507 ± 0.021 0.509 ± 0.226 0.509 ± 0.023
Ratio of organ:final body weight (%)
Testes 0.60 ± 0.06 0.58 ± 0.06 0.66 ± 0.05 0.59 ± 0.06
Epididymides 0.25 ± 0.02 0.27 ± 0.02 0.26 ± 0.03 0.28 ± 0.01
Seminal vesicles 0.71 ± 0.15 0.78 ± 0.23 0.73 ± 0.08 0.77 ± 0.08
Liver 5.30 ± 0.55 5.44 ± 0.62 5.08 ± 0.58 5.01 ± 0.39
Brain 1.16 ± 0.04 1.21 ± 0.07 1.21 ± 0.07 1.21 ± 0.06
Notes: Gavage treatment consisted of MTBE in corn oil on days 1, 3, and 5 at doses of 0 (vehicle only), 400, 1000 or 2000 mg/kg MTBE, n=6. 2.5 
IU/g body weight hCG was administered ip on day 6 and necropsy was on day 7. Values in the table are mean ± standard deviation. No significant 
differences were observed across the groups (p>0.05).
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Table 2
Testosterone and testis histology after MTBE exposure: 7-day study in adult male CD-1 mice
MTBE treatment
+2.5 IU hCG/g
Serum testosterone
(ng/ml)1
Testis histology
Corn oil control 30.14 ± 21.45 1 of 6 animals had mild
unilateral seminiferous tubule
degeneration
400 mg/kg MTBE 19.16 ± 7.28 NSL2
1000 mg/kg MTBE 27.56 ± 6.47 NSL
2000 mg/kg MTBE 36.08 ± 15.51 NSL
Notes: Gavage treatment consisted of MTBE in corn oil on days 1, 3, and 5 at doses of 0 (vehicle only), 400, 1000 or 2000 mg/kg MTBE, n=6. 2.5 
IU/g body weight hCG was administered ip on day 6 and necropsy was on day 7.
1
Mean ± standard deviation. No significant difference was observed across the groups (p>0.05)
2NSL = No significant lesions.
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Table 3
Water and MTBE consumption by male BALB/c mice in the two drinking water studies
Group
Adults
28-day exposure
(n=6)
Juveniles
51-day exposure
(n=10)
Mean water
consumption
(ml/day/mouse)
Mean MTBE
consumption
(µg/day/mouse)
Mean water
consumption
(ml/day/mouse)
Mean MTBE
consumption
(µg/day/mouse)
Tap water
control 3.95 ± 0.59 0 4.87 ± 0.35 0
80 ppb
MTBE 3.81 ± 0.27 0.305 4.76 ± 0.29 0.381
800 ppb
MTBE 3.97 ± 0.29 3.18 4.87 ± 0.47 3.90
8000 ppb
MTBE 3.99 ± 0.43 31.92 4.90 ± 0.49 39.17
Notes: Values shown are mean ± standard deviation. Juveniles were exposed from PND 25–26 to PND 76–77. No significant differences were 
observed in mean water consumption across the groups in either experiment (p>0.05).
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Table 4
Body and organ weights after MTBE exposure: 28-day drinking water study in adult male BALB/c mice
Tap water control 80 ppb MTBE 800 ppb MTBE 8000 ppb
MTBE
Absolute weight (g)
Final body weight 28.0 ± 1.7 27.8 ± 2.0 28.5 ± 1.1 27.1 ± 2.1
Testes 0.202 ± 0.01 0.208 ± 0.02 0.208 ± 0.02 0.192 ± 0.01
Epididymides 0.073 ± 0.01 0.074 ± 0.01 0.074 ±0.01 0.072 ± 0.01
Seminal vesicles 0.25 ± 0.07 0.23 ± 0.06 0.21 ± 0.05 0.23 ± 0.06
Liver 1.50 ± 0.13 1.48 ± 0.21 1.57 ± 0.09 1.49 ± 0.13
Brain 0.43 ± 0.03 0.44 ± 0.02 0.44 ± 0.04 0.41 ± 0.04
Ratio of organ:final body weight (%)
Testes 0.72 ± 0.03 0.75 ± 0.08 0.73 ± 0.04 0.71 ± 0.05
Epididymides 0.26 ± 0.02 0.27 ± 0.03 0.26 ± 0.02 0.25 ± 0.02
Seminal vesicles 0.91 ± 0.25 0.82 ± 0.18 0.73 ± 0.18 0.85 ± 0.16
Liver 5.33 ± 0.34 5.30 ± 0.42 5.48 ± 0.35 5.48 ± 0.19
Brain 1.56 ± 0.12 1.59 ± 0.15 1.56 ± 0.10 1.53 ± 0.14
Note: Values shown are mean ±standard deviation, n=6. No significant differences were observed across the groups (p>0.05).
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Table 5
Testosterone, sperm count, and testis histology after MTBE exposure: 28-day drinking water study in adult 
BALB/c mice
Group Serum
testosterone
(ng/ml)1
Sperm per mg cauda ×
105)
Testis histology
Tap water
control
2.61 ± 1.56 3.33 ± 0.98 2 mice with unilateral
seminiferous tubule
degeneration, 1 mild (grade 2),
1 minimal (grade 1)
80 ppb MTBE 2.21 ± 3.42 3.66 ± 1.03 1 mouse with unilateral
seminiferous tubule
degeneration, minimal (grade 1)
800 ppb MTBE 3.71 ± 7.46 2.79 ± 0.32 1 mouse with unilateral
seminiferous tubule
degeneration, minimal (grade 1)
8000 ppb MTBE 1.63 ± 0.89 3.06 ± 1.01 2 mice with unilateral
seminiferous tubule
degeneration, both minimal
(grade 1)
Notes: Values are mean ± standard deviation, n=6. No significant differences observed across the treatment groups (p>0.05)
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Table 6
Final body and organ weights after MTBE exposure: 51-day drinking water study of juvenile male BALB/c 
mice
Tap water
control
80 ppb MTBE 800 ppb MTBE 8000 ppb
MTBE
Absolute weight (g)
Final body
weight
Testes
26.5 ± 1.40
0.195 ± 0.011
25.9 ± 1.17
0.196 ± 0.009
25.2 ± 1.71
0.188 ± 0.018
25.5 ± 0.610
0.183 ± 0.019
Epididymides 0.074 ± 0.005 0.075 ± 0.007 0.073 ± 0.007 0.075 ± 0.007
Seminal vesicles 0.169 ± 0.016 0.185 ± 0.026 0.167 ± 0.025 0.165 ± 0.032
Liver 1.41 ± 0.096 1.38 ± 0.118 1.40 ± 0.136 1.41 ± 0.090
Kidneys 0.424 ± 0.037 0.421 ± 0.039 0.411 ± 0.033 0.402 ± 0.033
Brain 0.413 ± 0.018 0.399 ± 0.020 0.401 ± 0.022 0.401 ± 0.021
Spleen 0.100 ± 0.009 0.090 ± 0.010 0.084 ± 0.011 0.089 ± 0.006
Heart 0.145 ± 0.013 0.144 ± 0.017 0.144 ± 0.022 0.137 ± 0.007
Lungs 0.180 ± 0.033 0.191 ± 0.037 0.228 ± 0.072 0.210 ± 0.050
Ratio of organ:final body weight (%)
Testes 0.74 ± 0.04 0.76 ± 0.04 0.75 ± 0.07 0.72 ± 0.07
Epididymides 0.28 ± 0.03 0.29 ± 0.07 0.29 ± 0.02 0.29 ± 0.03
Seminal vesicles 0.64 ± 0.09 0.72 ± 0.09* 0.66 ± 0.08 0.65 ± 0.13
Liver 5.34 ± 0.23 5.33 ± 0.31 5.55 ± 0.38 5.54 ± 0.31
Kidneys 1.60 ± 0.12 1.63 ± 0.10 1.63 ± 0.11 1.57 ± 0.11
Brain 1.56 ± 0.04 1.55 ± 0.07 1.59 ± 0.10 1.57 ± 0.08
Spleen 0.38 ± 0.02 0.35 ± 0.03 0.33 ± 0.04 0.35 ± 0.02
Heart 0.55 ± 0.04 0.56 ± 0.05 0.57 ± 0.07 0.54 ± 0.03
Lungs 0.68 ± 0.12 0.74 ± 0.17 0.90 ± 0.26* 0.82 ± 0.19
Notes: Values are mean ± standard deviation; n=10.
*Statistically different from tap water control (p<0.05). Mice were exposed from PND 25–26 to PND 76–77.
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Table 7
Seminiferous tubule diameter and histology of testes and epididymides: 51-day study of juvenile male 
BALB/c mice
Group
(n=10)
Mean group tubule
diameter
(µm)1
Histology findings
Tap water control 208 ± 14 NSL2
80 ppb MTBE 210 ± 9 NSL
800 ppb MTBE 212 ± 12 NSL
8000 ppb MTBE 208 ± 7 NSL
Notes: Mice were exposed from PND 25–26 to PND 76–77.
1
Mean ± standard deviation. No significant difference across the groups (p>0.05)
2NSL=No significant lesions were noted in any of the H&E- or PASH-stained slides of epididymides or testes. See Materials and methods for 
explanation of lesions considered significant.
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Table 8
Serum testosterone and estradiol after MTBE exposure: 51-day drinking water study of juvenile male BALB/c 
mice
Group
(n=10)
Testosterone
(ng/ml)
17β-Estradiol
(pg/ml)
Tap water control 7.44 ± 9.94 37.32 ± 8.67
80 ppb MTBE 2.00 ± 3.79 35.89 ± 8.97
800 ppb MTBE 9.83 ± 15.47 36.50 ± 20.29
8000 ppb MTBE 12.50 ± 17.15 32.50 ± 10.10
Note: Mice were exposed from PND 25–26 to PND 76–77. Values in table are mean ± standard deviation; n=10. No statistically significant 
differences were observed across the groups (p>0.05).
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N
ot
es
: M
ic
e 
w
er
e 
ex
po
se
d 
fro
m
 P
N
D
 2
5–
26
 to
 P
N
D
 7
6–
77
.
M
D
A
 =
 m
al
on
di
al
de
hy
de
TE
A
C 
= 
Tr
ol
ox
 e
qu
iv
al
en
t a
nt
io
xi
da
nt
 c
ap
ac
ity
8O
H
2d
G
= 
8-
hy
dr
ox
y-
2’
-d
eo
xy
gu
an
os
in
e;
 a
dd
uc
ts=
ra
tio
 o
f 8
O
H
2d
G
/2
dG
V
al
ue
s a
re
 m
ea
n 
± 
sta
nd
ar
d 
de
vi
at
io
n;
 n
=1
0 
fo
r t
he
 M
D
A
 a
nd
 T
EA
C 
as
sa
ys
; n
=5
 fo
r 8
O
H
2d
G
 ad
du
ct
s.
N
o 
sig
ni
fic
an
t d
iff
er
en
ce
s a
cr
os
s t
he
 g
ro
up
s (
p>
0.0
5).
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